Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 62.20B | 60.95B | 53.97B | 45.67B | 38.90B | 35.96B |
Gross Profit | 52.99B | 50.04B | 47.54B | 40.10B | 34.44B | 32.00B |
EBITDA | 11.50B | 12.14B | 13.27B | 11.76B | 10.27B | 8.74B |
Net Income | 6.83B | 6.05B | 7.23B | 6.41B | 5.41B | 4.80B |
Balance Sheet | ||||||
Total Assets | 72.33B | 76.54B | 72.47B | 65.10B | 56.59B | 49.44B |
Cash, Cash Equivalents and Short-Term Investments | 13.01B | 16.18B | 18.24B | 16.96B | 14.64B | 10.54B |
Total Debt | 7.90B | 8.05B | 6.43B | 8.33B | 10.37B | 13.52B |
Total Liabilities | 28.43B | 29.22B | 28.19B | 26.68B | 26.59B | 26.79B |
Stockholders Equity | 43.90B | 47.32B | 44.28B | 38.42B | 29.99B | 22.66B |
Cash Flow | ||||||
Free Cash Flow | 3.09B | 5.38B | 6.06B | 5.59B | 7.81B | 4.73B |
Operating Cash Flow | 3.19B | 5.81B | 9.77B | 8.50B | 9.82B | 6.77B |
Investing Cash Flow | -942.50M | -4.07B | -3.74B | -3.76B | -2.08B | -1.78B |
Financing Cash Flow | -3.31B | -4.15B | -5.02B | -3.04B | -3.99B | -5.22B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
73 Outperform | ¥45.95B | 73.27 | ― | 1.53% | 19.05% | -31.67% | |
66 Neutral | ¥307.20B | 49.52 | ― | 0.34% | 29.09% | 87.01% | |
66 Neutral | ¥133.18B | 18.73 | ― | 1.87% | 10.66% | 0.41% | |
65 Neutral | ¥22.00B | 21.63 | ― | 1.62% | 13.39% | 12.00% | |
60 Neutral | €70.97B | 48.83 | 8.00% | ― | 34.77% | -46.50% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
43 Neutral | ¥17.67B | 4,465.71 | ― | 1.19% | -0.58% | -260.22% |